Abstract B091: A Phase 1b study of neoadjuvant-adjuvant pembrolizumab in resectable advanced basal cell carcinoma reveals robust T cell expansion, driving a memory-like subtype with promising therapeutic potential
Year: 2025
Type: conference-abstract
Source: Cancer Immunology Research
Institutions: Cleveland Clinic, Stanford Cancer Institute, Stanford University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407866470
